Navigation Links
Galmed Pharmaceuticals Reports First Half 2014 Financial Results


Liabilities and Stockholders' DeficiencyCurrent liabilitiesTrade payables$

Other accounts payable393

334Total current liabilities694

1,689Long-term liabilities Related parties442

428Total long-term liabilities442

428Stockholders' equity (deficiency):Ordinary shares par value NIS 0.01 per share; 
Authorized 50,000,000; Issued and outstanding:
11,100,453 shares as of June 30, 201432

-Ordinary shares par value $1 per share; Authorized 50,000
shares; Issued and outstanding: 9,739 shares as of
December 31, 2013-

10Additional paid-in capital67,876

25,681Accumulated deficit (31,560)

(27,642)Total stockholders' equity (deficiency)36,348

(1,951)Total liabilities and stockholders' equity$

The noted included in the 6-K are an integral part of the condensed interim consolidated financial statements. GALMED PHARMACEUTICALS LTD.Condensed Consolidated Statements of OperationsU.S. Dollars in thousands, except share data and per share dataSuccessorPredecessor 

Period from February 3 to June 30, 2014Period from
January 1 to '/>"/>

SOURCE Galmed Pharmaceuticals Ltd.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
3. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
4. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
5. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
6. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
7. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
8. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
9. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
10. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
11. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
Post Your Comments:
(Date:10/9/2015)... and ROCKVILLE, Md. , Oct. ... privately-held biotechnology company developing next generation vaccines based ... has entered into an exclusive worldwide licensing agreement ... the treatment or prevention of any and all ... agreement, Immunomic Therapeutics will receive an upfront payment ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... us. However, the current methods of separating those cells from their surroundings for ... damaging to the cells. , To address this, Ann Arbor-based startup Akadeum ...
(Date:10/8/2015)... 2015   Intrexon Corporation (NYSE: XON ... appointment of Joseph L. Vaillancourt as Senior ... Nimrodi who continues in his role as Head ... to generate sustainable, biologically based solutions to environmental problems. ... held a variety of key roles including, Vice President ...
(Date:10/8/2015)... Va. , Oct. 8, 2015  ATCC, the ... today that it has been selected by The Michael ... vital cell lines to academic, pharmaceutical, and biotechnology organizations ... the United States , and ... --> the United States , and ...
Breaking Biology Technology:
... Preventative Testing , , CINCINNATI, June 23 ... nation,s leading provider of physician office-based patient-education programs, reports ... programs, 16.9 percent more patients had PSA tests (prostate ... (colon cancer screening) compared to patients in practices without ...
... ... MasterControl Inc., a global provider of GxP process and document ... world leading provider of high performance electronic regulatory submission solutions for ... the Drug Information Association (DIA) 45th Annual Meeting. GxP2eCTD is ...
... June 23 SyntheMed, Inc. (OTC Bulletin Board: SYMD), ... of anti-adhesion products, announced today that the company was ... Innovation Award in pediatrics. The company is ... Sullivan medical device analysts in recognition of the development ...
Cached Biology Technology:
(Date:9/10/2015)... 2015 Report Details Emerging ... Opportunities and Revenue Prospects to Help You Stay ... especially new drug classes? Get the latest technological ... exclusive market data and industry knowledge, benefitting your ... opportunities and sales predictions. Visiongain,s new study ...
(Date:9/8/2015)... --  TREW Marketing and today ... for Engineers TM : Content and Online Marketing . ... about engineers, preferences for online content marketing and channels ... and trust, and where they look for that content ... with how to best implement online and content marketing ...
(Date:9/1/2015)... MOUNTAIN VIEW, Calif. , Sept. 1, 2015 ... interaction with travelers during airport passenger screening. This ... which the passenger screening process will become unintrusive. ... and pre-clearance based on voluntary background investigations will ... analysis from Frost & Sullivan, Global Airport ...
Breaking Biology News(10 mins):
... MEDFORD/SOMERVILLE, Mass. Maria Flytzani-Stephanopoulos of Tufts University,s ... AAAS Fellow for distinguished contributions to the field ... reactions on nanoscale metal oxides in fuel conversion ... is an honor bestowed upon AAS members by ...
... Eight Arizona State University faculty members are among ... for the Advancement of Science (AAAS), a prestigious international ... society. Brad Allenby, Richard Creath, James Elser, Patricia ... Spence will be recognized Feb. 14 at the Fellows ...
... experiment, researchers have provided some clues to one of ... together to form the basis of life. ... JBC , demonstrated how ancient RNA joined together to ... precursor to DNA, normally expands one nucleic base at ...
Cached Biology News:
Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
... Adapted to Sf-900 II ... isolated from Spodoptera frugiperda ... cells (1). The Sf21 ... serum-free suspension culture in ...
MAGP-2 (C-19)...
TGF-beta 2 MAb (Clone 8607)...
Biology Products: